Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US DoJ warns medtech industry of global bribery crackdown

This article was originally published in Clinica

Executive Summary

The US Department of Justice is carrying out a formal investigation into the entire medical technology industry to “root out” behaviour that violates the Foreign Corrupt Practices Act. In addition, the department’s foreign counterparts are stepping up their anti-bribery enforcement efforts. Therefore, companies need to increase their focus on foreign bribery compliance. So said Kathleen Hamann, a trial attorney in the fraud section of the DoJ’s Criminal Division, who was speaking at the 2010 International Medical Device Industry Compliance Conference taking place this week in Berlin, Germany.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094616

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel